Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non‐small cell lung cancer

BACKGROUND: Here, we aimed to assess the association of ALK variants and alterations with ensartinib response duration in NSCLC, and explore the potential value of computed tomography (CT) radiomic features in predicting progression‐free survival (PFS). METHODS: We enrolled 88 patients with identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Donghui, Zheng, Xiaomin, Song, Wei, Liu, Xiaoqing, Wang, Sicong, Zhou, Lina, Tao, Xiuli, Lv, Lv, Sun, Qi, Jin, Yujing, Zhang, Zewei, Ding, Lieming, Wu, Ning, Zhao, Shijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410530/
https://www.ncbi.nlm.nih.gov/pubmed/34288491
http://dx.doi.org/10.1111/1759-7714.14083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410530/
https://www.ncbi.nlm.nih.gov/pubmed/34288491
http://dx.doi.org/10.1111/1759-7714.14083

Ejemplares similares